-
Mashup Score: 11ClinicalTrials.gov - 2 month(s) ago
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Source: clinicaltrials.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 26CPRIT awards more than $60 million to boost Texas’ fight against cancer — Cancer Prevention and Research Institute of Texas - 5 month(s) ago
Texans voted in 2007 to create the Cancer Prevention & Research Institute of Texas (CPRIT) and to invest $3 billion in the state’s unprecedented fight against cancer. On November 5, 2019, Texas voters overwhelmingly approved a constitutional amendment to continue CPRIT’s work and invest an additional $3 billion for finding and funding the best cancer research and prevention opportunities in the state. CPRIT is now a $6 billion, 20-year initiative – the largest state cancer research investment in the history of the United States and the second largest cancer research and prevention program in the world.
Source: www.cprit.texas.govCategories: General Medicine News, Hem/OncsTweet-
Pleased to recognize these CPRIT grants to @utswcancer members that should enhance our peer-reviewed funding #s in the upcoming competing renewal of our NCI core grant & comprehensive designation. Great for the our mission in North Texas & beyond! https://t.co/zT41EXdcuk
-
-
Mashup Score: 3Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide survey - PubMed - 8 month(s) ago
We conducted a national in-depth analysis including pharmacovigilance reports and clinical study to assess the reporting rate (RR) and to determine the clinical profile of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) in COVID-19-vaccinated individuals. First, based on the French pharm …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, RheumatologyTweet-
National French study finds post COVID Vaccine the IR of PMR (179 cases; RR 7.1/mill) & GCA (54 cases; RR 2.1 /million) were reported 7-10d post vax. These #s are below population incidence rates (1-20/mill for GCA) https://t.co/XvaoWhqs2g https://t.co/BFDy2WKcLx
-
-
Mashup Score: 3Frontiers | The efficacy and safety of short-term and low-dose IL-2 combined with tocilizumab to treat rheumatoid arthritis - 9 month(s) ago
BackgroundImmunotherapy targeting factors related to immune imbalance has been widely employed for RA treatment. This study aimed to evaluate the efficacy an…
Source: www.frontiersin.orgCategories: General Medicine News, General HCPsTweet-
50 active RA pts RCT Rx w. either low dose IL-2(n=26), IL-2+TCZ (9) or control (15). All improved clinically by DAS28-ESR, but IL-2 Rx pts had signif proliferation of Tregs, w. decr inTh1, Th2, & Th17 cells. TREG #s correlated w/ ESR drop (r=0.54) https://t.co/1tF63FuXzx https://t.co/M5TWsa6zI4
-
-
Mashup Score: 1NORD® Learning – Empowering through education - 1 year(s) ago
Skip to content About NORD NORD, a 501(c)(3) organization, is a patient advocacy organization dedicated to individuals with rare diseases and the organizations that serve them. NORD, along with its more than 330 patient organization…
Source: learn.rarediseases.orgCategories: Latest Headlines, Rare DiseaseTweet-
Dear @RareDiseases @CPathInstitute I love what I just saw to educate https://t.co/nMmm1BU1OR ... but pls offer some citations every time you quote yrs it takes to develop a drug or $ required, etc. These #s become repeated & exaggerated w/o some mooring in facts. Tx. #NORDSummit
-
-
Mashup Score: 2
AbstractAims. Patients with cardiomyopathies and channelopathies are usually younger and have a predominantly arrhythmia-related prognosis; they have nearly nor
Source: academic.oup.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Long-term outcomes of S-ICD in patients with channelopathies and cardiomyopathies 👉 https://t.co/fqBKFeg5wA @EuropaceEiC @GiulioConte9 @Dominik_Linz @FraSantoroMD @AndyZhangMD @marcovitoloMD #genetics #Europace #S-ICD https://t.co/q7OrG9CMtc
-
-
Mashup Score: 0Trends in Deaths From Falls Among Adults Aged 65 Years or Older in the US, 1999-2020 - 2 year(s) ago
This study examines trends in deaths from falls among adults aged 65 years or older by sex and by race and ethnicity between 1999 and 2020 in the US.
Source: jamanetwork.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
JAMA: n 2020, 42 114 deaths in the US were related to falls, with 86% occurring among adults aged >65 years. Falls are a leading cause of injury and leading causes of death among older adults in the US - And these #s are increasing betw '99 & 2020 https://t.co/3sXSCXZ8Q6 https://t.co/PSi3xcT8fJ
-
-
Mashup Score: 0
Biosimilars offer cost-effective and safe treatment options both for patients and healthcare systems. CT-P10 is the first biosimilar of rituximab approved in Europe for use in all indications of originator rituximab (oRTX). This study aimed to provide real-life data on treatment changes and adverse events in patients who received oRTX or CT-P10. We retrospectively reviewed treatment-related…
Source: SpringerLinkCategories: Latest Headlines, RheumatologyTweet-
Real world interchangeabilty study compared rituximab to biosimilar ( CT-P10) in 128 Rheum pts (CT-P10= 64; RTX= 64), with 41% of pts switched from RTX to CT-P10. Both Rx had Comparable Gr 2 infuxion Rxs, infection #s & hypogammaglobulinemia (p > 0.05) https://t.co/RNxt7Xn7MJ https://t.co/u3yJNQQIMC
-
-
Mashup Score: 0Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant - Nature Communications - 2 year(s) ago
Multiple myeloma (MM) is treated with induction chemotherapy, autologous stem cell transplant (ASCT) and long-term immunomodulatory drug (IMiD) maintenance. Here, the authors show that the presence of clonal haematopoiesis of indeterminate potential (CHIP) at time of ASCT is associated with adverse outcomes in MM patients.
Source: NatureCategories: Hem/Oncs, Latest HeadlinesTweet-
@RenoHemonc @BloodAdvances Unclear--in this paper, CH was not associated w/ risk of t-MN in MM pts, but small #s and it does appear that CH clones present prior to autologous HCT may drive subsequent therapy-related myeloid neoplasia in some (https://t.co/f7btRidcFG).
-
-
Mashup Score: 25
More than a million people have called out sick for the past three years, and CDC says long Covid probably a contributor too
Source: the GuardianCategories: Expert Picks, Latest HeadlinesTweet-
7% of people have long covid right now! 20% of people who had covid develop long covid Millions out sick with long covid Such hard hitting science reporting! Never probing where #s come from Next time it snows in Tahoe, I will be out sick with long COVID https://t.co/Z6xhXw1RT4
-
Thx! Didn't know trial. Results posted: https://t.co/F2jENcy2Q5 Small trial (n=48), but #s favor SBRT > TACE for bridging: Less progression (11% v 38% at 1 yr) Less additional pre-transplant tx needed: 5% vs. 21% Better radiographic response: 95% vs. 80% 0 deaths (vs. 1) https://t.co/106oOMNom4 https://t.co/aXPyQAAbf8